MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register
About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Industry news

Shire Targets Fourth Quarter Filing of BLA for REPLAGAL

In order to access this content you must be logged in and have a subscription to PL Intelligence.

PLi

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.

Subscribe now for instant access to the benefits PL Intelligence has to offer. Find out more.

Company details

If you want to find out more about the company visit Shire Pharmaceuticals profile.

Related news

Latest News

Novartis launches Prevacid
Covidien Introduces First FDA-Approved Spine Sealant
The European Commission grants Orphan Drug designation for NGR-hTNF in the treatment of hepatocellular carcinoma
Kensey Nash Receives FDA 510(k) Clearance for Porcine Dermis Biologic Product
Pandemic 2009 Influenza Update: US FDA approves GSK's pandemic H1N1 vaccine
IRONWOOD AND ASTELLAS ANNOUNCE JAPAN LICENSING AGREEMENT FOR LINACLOTIDE
Merit Medical Announces 510(K) Clearance for the Merit Laureate(TM) Hydrophilic Guide Wire
Lonza successfully develops a manufacturing process for ArzerraTM (ofatumumab), a new biopharmaceutical from GSK and Genmab
Teva Receives Favorable Court Decision Regarding Generic Prevacid
Teva Receives Final Approval For Generic Prevacid
More news... | RSS Feed...

Most Viewed

FDA GRANTS ORPHAN DRUG DESIGNATION FOR TNFERADE(TM)

Shire Targets Fourth Quarter Filing of BLA for REPLAGAL

Cephalon Notified of Generic Filing for Armodafinil Tablets

ONCOLYS BIOPHARMA SIGN STRATEGIC ALLIANCE AND LICENSE AGREEMENT WITH ASTELLAS PHARMA TO DEVELOP AND COMMERCIALIZE YM753 HDAC INHIBITOR DRUG

The European Commission grants Orphan Drug designation for NGR-hTNF in the treatment of hepatocellular carcinoma

Acorda Therapeutics Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010

Tarix Pharmaceuticals receives IND to treat HIV patients with persistently low CD4 counts

Tarix Pharmaceuticals receives FDA approval for Phase 2 study to mitigate chemotherapy-induced thrombocytopenia

Antigenics Announces a Negative Vote From the CHMP on Oncophage

BioServe Selected by Government of A.P. India to Test H1N1 (Swine Flu) Patients

Therapeutic Target

Cardiovascular
Dermatology
Endocrine and Metabolic
Gastroenterology
Genitourinary
Hematology
Immunology and Allergy
Infection
Musculoskeletal
Neurology
Obstetrics and Gynecology
Oncology
Ophthalmology
Psychiatry
Pulmonary

Categories

Deals and Alliances
Development
Financial Results
Financings
Intellectual Property
Regulatory
Press releases
Deals review
Headlines
PR Newswire

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us